Life Sciences

FDA warns Protherics for Web page, fact sheet

Pharma Compliance Alert, November 26, 2008

Protherics Inc.’s Web page and fact sheet for its investigational new drug Voraxaze misbrand the product, according to an FDA warning letter.

Post a Comment

Name:

 

E-mail:

 

Please enter your comment below:

   

Please enter the text below:

   
   

Most Popular